ArticleCureus2025
Efficacy of a Y-modified Transconjunctival Approach for Open Reduction and Internal Fixation of Zygomaticomaxillary Complex Fractures: Functional Recovery and Cosmetic Outcomes.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionFractures of the zygomaticomaxillary complex (ZMC), a crucial component of the midface, frequently lead to functional impairments, such as diplopia, enophthalmos, and restricted ocular motility. Although surgical intervention is often required, conventional techniques can be limited by suboptimal access and potential aesthetic drawbacks. This study prospectively assessed the efficacy, functional recovery, and cosmetic results of the Y-modified transconjunctival technique for managing ZMC fractures with concomitant orbital floor injury. MATERIALS AND
methodsA prospective cohort study was conducted at a single oral and maxillofacial surgery department. Fifteen eligible patients (aged 18-65 years) presenting with displaced ZMC fractures and orbital floor defects were treated with open reduction and internal fixation using the Y-modified transconjunctival approach. Outcome measures included pain (Visual Analog Scale (VAS) score), enophthalmos (Hertel exophthalmometer), scar quality (Patient and Observer Scar Assessment Scale (POSAS) 3.0), and paresthesia. Fracture reduction and implant position were verified using high-resolution computed tomography. Patients were systematically evaluated postoperatively on days 1, 10, 28, and 42, and the data were subjected to statistical analysis.
resultsThe results demonstrated a statistically significant reduction in pain levels over time, with mean VAS scores declining from 5.82 on postoperative day 1 to 1.00 by day 42 (p < 0.01). Residual enophthalmos was observed in a single case (6.67%). Objective scar evaluation using POSAS 3.0 indicated marked improvements in vascularity, pigmentation, and pliability between the 10- and 28-day assessments (p < 0.01). Furthermore, patient-reported feedback corroborated these findings, indicating a diminished perception of discomfort and a positive view of scar healing.
conclusionsThe Y-modified transconjunctival approach proved to be an effective strategy for ZMC fractures with orbital floor involvement, providing ample surgical exposure for stable fixation while yielding excellent functional and aesthetic outcomes. However, the promising results should be interpreted in the context of the study's limitations, including a modest sample size and single-institution design. Future research involving larger multicenter cohorts with long-term follow-up is necessary to confirm these preliminary findings and establish broader clinical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.